Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …

Introduction Hepatocellular carcinoma (HCC) is the most common primary liver cancer and
fourth-leading cause of cancer death. While drug discovery to improve disease survival was …

Radiomic image features are becoming a promising non-invasive method to obtain
quantitative measurements for tumour classification and therapy response assessment in …

Simple Summary STAT3 is a major oncogenic transcription factor that is constitutively
activated in many types of human cancers, including hepatocellular carcinoma (HCC) and …

Background Circular RNA hsa_circ_0061395 (circ_0061395) has been reported to
accelerate the advancement of hepatocellular carcinoma (HCC). However, the regulatory …

Simple Summary Hepatocellular carcinoma accounts for around 75% of all liver cancers,
and represents the fourth most common cause of cancer-related deaths worldwide …

Hepatocellular carcinoma (HCC) has a poor prognosis and a low survival rate. Drugs
without side effects are desperately needed since chemotherapy has a negative effect on …

Glypican-3 (GPC3) is an oncofetal antigen that is highly expressed in multiple solid tumors,
including hepatocellular carcinoma, and is barely expressed in adult normal tissues except …

Targeting cytokinesis can suppress tumor growth by blocking cell division and promoting
apoptosis. We aimed to characterize key cytokinesis regulator in hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable
diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic …